S
Sproutly Canada Inc
CNSX:SPR
Sproutly Canada Inc
CNSX:SPR
Price:
0.02
CAD
Market Closed
Market Cap:
CA$5.3m
Relative Value
There is not enough data to reliably calculate the relative value of SPR.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SPR
Relative Value
Base Case
Not Available
Multiples Across Competitors
SPR Competitors Multiples
Sproutly Canada Inc Competitors
Sproutly Canada Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
S
|
Sproutly Canada Inc
CNSX:SPR
|
5.3m CAD | 10.4 | -0.4 | -3.6 | -3.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD | 15.2 | 48 | 32.3 | 34.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
591.4B USD | 6.3 | 22.1 | 15.3 | 18.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
292.8B CHF | 4.8 | 31.3 | 13.2 | 15.4 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.2B GBP | 5.5 | 31.7 | 17.5 | 24.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
244.9B CHF | 5.6 | 22.6 | 13.9 | 17.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
307.5B USD | 4.7 | 16.8 | 10.5 | 12.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK | 3.7 | 11.3 | 8.3 | 9.8 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.9B USD | 2.5 | 19.8 | 7.4 | 9.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.8B USD | 2.6 | 17.5 | 7.3 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
